Key facts
- Stem cells extracted from gum tissue were used to treat Type 1 diabetes.
- More than half of trial participants showed improvement.
- One patient achieved complete independence from exogenous insulin therapy.
A Phase 1 clinical trial in China has demonstrated encouraging results in treating Type 1 diabetes using stem cells derived from gum tissue. Researchers reported that over half of the patients who received the therapy showed varying degrees of improvement. In one notable case, a subject was able to completely discontinue exogenous insulin therapy.